Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Blow For Novartis As England’s NICE Says No To Kisqali
Apr 10 2019
•
By
Neena Brizmohun
NICE is not ready to recommend Kisqali's use on the NHS • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Health Technology Assessment
More from Market Access